🇺🇸 FDA
Pipeline program

Pazopanib

VEG105424

Phase 1 small_molecule completed

Quick answer

Pazopanib for Neoplasms, Colorectal is a Phase 1 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline
Indication
Neoplasms, Colorectal
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials